IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy of Neurology (EAN) ...Middle East

SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that results...

Read More Details
Finally We wish PressBee provided you with enough information of ( IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy of Neurology (EAN) )

Also on site :

• A Local Mystic's Favorite Spots in "Witch City" Salem, MA
• ‘Contaminated’ snack sold at Trader Joe’s recalled after ‘life-threatening’ bacteria found – 4 groups at higher risk
• Bianca Censori Wears Edible Lingerie in Public With Kanye West